← SynDRA
DIMETHISOQUIN
SynDRA canonical compound SYN0004516 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Mechanism of action | local anesthetic |
| Indication | local anesthetic |
| Disease area | neurology/psychiatry |
All known targets
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- GMNN
- TARDBP
- SAMHD1
- PTH1R
- POLI
- LMNA
- KAT2A
- HDAC6
- GLP1R
- ALOX15B
- EHMT2
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- ATAD5
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- ACM1
- ANDR
- CP1A2
- CP2D6
- CP3A7
- GCR
- GLI3
- JUN
- KCNH2
- NSD2
- NTM1A
- NTMT1
Drug classes
- Anesthetics
- Anesthetics, Local
- Central Nervous System Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- local anesthetic
ATC classes
- D04A · ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
Cross-references
Synonyms
- quinisocaine
- quinisocaine hydrochloride
- quinisocain
- quinoleine
- dimethisoquin hydrochloride
- dimethisoquin HCl
- Quinisocaine
- Quinisocaina
- NSC-39695
- Quinisocain
- Histaderme
- Isochinol
- Pruralgan
- Quinoleine
- Chinisocain
- Prulantex
- Pruralgin
- 2-(3-butylisoquinolin-1-yl)oxy-N,N-dimethylethanamine
- Quotane
- NSC 39695
- 772EN3BH6I
- ISOQUINOLINE, 3-BUTYL-1-(2-(DIMETHYLAMINO)ETHOXY)-
- Ethanamine, 2-((3-butyl-1-isoquinolinyl)oxy)-N,N-dimethyl-
- 3-Butyl-1-[2-(dimethylamino)ethoxy]isoquinoline
- Quinisocaine (INN)
- Chinisocainum
- Ethanamine, 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethyl-
- QUINISOCAINE [INN]
- Quinisocainum
- Quinisocaine [INN:BAN]
- Quinisocainum [INN-Latin]
- Quinisocaina [INN-Spanish]
- NCGC00016618-01
- 3-Butyl-1-(2-dimethylaminoethoxy)isoquinoline
- EINECS 201-700-0
- CAS-2773-92-4
- Isoquinoline, 3-butyl-1-[2-(dimethylamino)ethoxy]-
Look up DIMETHISOQUIN in the interactive SynDRA portal →